CeQur

CeQur is focused on commercializing innovative insulin delivery solutions that enhance adherence and simplify diabetes care. The company's devices are crafted to free people living with diabetes from the burdens of multiple daily injections by offering a wearable, user-friendly alternative.

CeQur Simplicity redefines insulin therapy with a discreet, 4-day wearable Insulin Delivery Device that facilitates injection-free bolus dosing. Each patch can hold up to 200 units of rapid-acting insulin, delivered in two-unit increments, effectively replacing about twelve daily mealtime injections over four days. Clinical research indicates that nearly 90% of patients using CeQur Simplicity have reported better adherence to their insulin regimen compared to multiple daily injections. The device is clinically proven to enhance glycemic control, with users achieving significant improvements in A1C levels and time-in-range goals, offering a new level of convenience and control for individuals managing diabetes.